Ebola's secret weapon revealed

Researchers have discovered the mechanism behind one of the Ebola virus' most dangerous attributes: its ability to disarm the adaptive immune system.

University of Texas Medical Branch at Galveston scientists determined that short-circuits the immune system using proteins that work together to shut down cellular signaling related to interferon. Disruption of this activity, the researchers found, allows Ebola to prevent the full development of dendritic cells that would otherwise trigger an immune response to the virus.

"Dendritic cells typically undergo a process called 'maturation' when they're infected by a virus—they change shape and present antigens on their surface that tell T-cells to attack that particular virus, thus generating an adaptive immune response," said UTMB professor Alexander Bukreyev, senior author of a paper on the discovery now online in the Journal of Virology. "But Ebola prevents dendritic-cell maturation and produces a severe infection without an effective . We found that its ability to do this depends on several specific regions of two different proteins."

Bukreyev's research group made the discovery after a series of procedures that started with a clone of the Ebola Zaire . Working under maximum-containment conditions in a biosafety level 4 facility in UTMB's Galveston National Laboratory, the team introduced mutations into the virus' at four locations thought to generate proteins that affected immune response.

They then infected human dendritic cells with each of the resulting new strains and compared the results with those produced by unmutated Ebola Zaire. Each of the four new viruses, they found, was unable to suppress dendritic-cell maturation.

"We saw two very interesting things," Bukreyev said. "First, that these mutations restore maturation of dendritic cells very effectively, and second, that a mutation in even one of these genetic domains makes the virus unable to suppress maturation. That means that the virus needs multiple combined effects in order to undermine the immune system in this way."

Ebola's ability to evade the human immune response is one of the factors that accounts for its high mortality rate—up to 90 percent in humans—and the notoriety that it gained after its first appearance in Zaire in 1976, in an outbreak that killed 280 people. Zaire—now the Democratic Republic of the Congo—is the home country of Ndongala Lubaki, lead author on the paper and a postdoctoral fellow at UTMB.

Related Stories

Scientists uncover Ebola cell-invasion strategy

Sep 03, 2008

University of Texas Medical Branch at Galveston researchers have discovered a key biochemical link in the process by which the Ebola Zaire virus infects cells — a critical step to finding a way to treat the deadly disease ...

Scientists block Ebola infection in cell-culture experiments

Jun 23, 2009

Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells. Using substances that block the activation of those pathways, they've ...

Researchers discover Ebola's deadly secret

Jan 19, 2010

(PhysOrg.com) -- Research at Iowa State University has led scientists to uncover how the deadly Zaire Ebola virus decoys cells and eventually kills them.

Recommended for you

Growing a blood vessel in a week

17 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

20 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments